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In Saccharomyces cerevisiae, the Wee1 family kinase Swe1p is normally stable during G1 and S phases but is
unstable during G2 and M phases due to ubiquitination and subsequent degradation. However, perturbations
of the actin cytoskeleton lead to a stabilization and accumulation of Swe1p. This response constitutes part of
a morphogenesis checkpoint that couples cell cycle progression to proper bud formation, but the basis for the
regulation of Swe1p degradation by the morphogenesis checkpoint remains unknown. Previous studies have
identified a protein kinase, Hsl1p, and a phylogenetically conserved protein of unknown function, Hsl7p, as
putative negative regulators of Swe1p. We report here that Hsl1p and Hsl7p act in concert to target Swe1p for
degradation. Both proteins are required for Swe1p degradation during the unperturbed cell cycle, and excess
Hsl1p accelerates Swe1p degradation in the G2-M phase. Hsl1p accumulates periodically during the cell cycle
and promotes the periodic phosphorylation of Hsl7p. Hsl7p can be detected in a complex with Swe1p in cell
lysates, and the overexpression of Hsl7p or Hsl1p produces an effective override of the G2 arrest imposed by
the morphogenesis checkpoint. These findings suggest that Hsl1p and Hsl7p interact directly with Swe1p to
promote its recognition by the ubiquitination complex, leading ultimately to its destruction.
Entry into mitosis is triggered by the activation of Cdc2-type
cyclin-dependent kinases (Cdc28p in Saccharomyces cerevisiae)
by mitotic B-type cyclins (35, 37). Cyclin B-Cdc2 complexes can
accumulate in an inactive form if the Cdc2 subunit is phos-
phorylated on a critical tyrosine residue (amino acid 19 in
Cdc28p) and, in some cells, also on the adjacent threonine
residue (10, 35). Checkpoint controls that regulate entry into
mitosis utilize this inhibitory phosphorylation to restrain acti-
vation of Cdc2 until key cell cycle events have been completed
(38, 42). Cdc2 tyrosine phosphorylation is catalyzed by Wee1-
related kinases (Swe1p in S. cerevisiae), and dephosphorylation
is catalyzed by Cdc25-related phosphatases (Mih1p in S. cer-
evisiae) (7, 10, 45). It is therefore of great interest to elucidate
the regulatory pathways that control the activity of the Wee1
family and Cdc25 family enzymes.
In S. cerevisiae, Cdc28p Tyr19 phosphorylation is induced by
the morphogenesis checkpoint, which helps to coordinate the
nuclear cycle with the process of bud development (22, 33).
For example, several environmental insults, including rapid
changes in ambient temperature or osmolarity, trigger a tem-
porary disruption of actin polarity, causing delays in bud for-
mation. The morphogenesis checkpoint responds by delaying
mitosis so that cells do not undergo nuclear division before a
bud has been constructed, thus preventing the formation of
binucleate cells (22, 33). The cell cycle delay induced by the
morphogenesis checkpoint requires Swe1p (49). Swe1p abun-
dance varies during the cell cycle as a result of regulated
transcription and degradation. SWE1 transcription is periodic,
with a peak in late G1 (24, 29, 49) phase, and Swe1p is stable
early in the cell cycle but becomes unstable during G2 and M
phases as a consequence of Cdc28p activation by the B-type
cyclins Clb1p to Clb4p (48). Thus, Swe1p accumulates during
late G1 and S phases and is degraded during G2-M in the
unperturbed cell cycle. However, Swe1p is stabilized in re-
sponse to perturbations of actin organization, and the resulting
persistence or continued accumulation of the protein (possibly
in conjunction with changes in its activity and/or localization)
leads to G2 arrest (48).
Two putative upstream regulators of Swe1p, Hsl1p and
Hsl7p, were discovered serendipitously during a genetic screen
for mutations displaying synthetic lethality with a deletion of
the amino terminus of histone H3 (HSL [histone synthetic
lethal]) (29). Although the basis for the genetic interaction
with histones was not clarified, the data suggested that Hsl1p
and Hsl7p act in some manner to lower the level of Swe1p
activity. In particular, it was found that hsl1 and hsl7 mutants
displayed a G2 delay that was eliminated upon deletion of
SWE1 (29). However, many mutants with defects in cell mor-
phogenesis display similar Swe1p-dependent G2 delays, pro-
duced by the morphogenesis checkpoint in response to the
mutant defect (33). It is therefore important to determine
whether Hsl1p and Hsl7p indeed act directly on Swe1p or
whether they simply cause a morphogenesis defect that acti-
vates the checkpoint response.
The sequence of Hsl7p has not yet suggested possible bio-
chemical activities for this protein, but homology searches have
identified close relatives in several other eukaryotes, including
Schizosaccharomyces pombe and humans (16, 29). In contrast,
support for the hypothesis that Hsl1p is a direct negative reg-
ulator of Swe1p has come from the similarity between the
kinase domain of Hsl1p and that of Nim1, an S. pombe protein
that has been shown to directly phosphorylate and inhibit
Wee1 (9, 40, 55). In addition, HSL1 (also called NIK1) was
isolated independently in a screen for S. cerevisiae genes that
could serve as multicopy suppressors of a temperature-sensi-
tive cdc2 mutant in S. pombe (54). This circumstantial evidence
suggests that Hsl1p may also act by directly phosphorylating
and inhibiting Swe1p. Homology searches have revealed that
S. cerevisiae contains two other kinases, Gin4p and Kcc4p, that
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are approximately as similar to Nim1 as is Hsl1p (4, 25). Re-
cently, it was suggested that these kinases play a redundant
role in Swe1p regulation (4). However, none of these kinases
has yet been shown to regulate Swe1p directly.
In this report, we provide evidence that both Hsl1p and
Hsl7p are bona fide negative regulators of Swe1p that appear
to function interdependently in a pathway that targets Swe1p
for degradation. During a checkpoint response, Hsl1p and
Hsl7p do not target Swe1p for degradation, suggesting that the
checkpoint mechanism may stabilize Swe1p by inhibiting Hsl1p
or Hsl7p function.
MATERIALS AND METHODS
Yeast strains and plasmids. Standard genetic and molecular biology methods
(30, 46) were used to generate all strains and plasmids used in this study, except
as indicated below. The yeast strains used are listed in Table 1. Plasmids con-
taining the swe1DLEU2 (7), mih1DLEU2 (45), GAL:SWE1myc:URA3 (33),
CDC28Y19F:TRP1 (48), hsl1DURA3 (29), and hsl7DURA3 (29) alleles have been
described previously; appropriate fragments were introduced into yeast strains by
direct transformation and confirmed by diagnostic PCR (26) and phenotypic
tests.
To create the SWE1myc:HIS2 allele, a 2.6-kb EcoRI/BamHI fragment con-
taining the COOH terminus of SWE1 tagged with one hemagglutinin (HA)
epitope, 12 myc epitopes, and downstream sequences was isolated from pRS306-
GAL:SWE1myc (33) and ligated into the EcoRI/BglII sites of vector YIpGAP2
(49). Digestion of this plasmid with KpnI targets integration to the SWE1 locus,
creating a full-length SWE1myc allele tagged with HIS2 adjacent to a 39 trun-
cated SWE1. To create the SWE1myc:TRP1 allele, a 4.0-kb PstI/BamHI fragment
containing the SWE1 gene and flanking sequences was removed from plasmid
pJM1024 (isolated from a YCp50 genomic library [44]) and ligated into the
corresponding sites of vector YIplac204 (14). A 2.0-kb ClaI/BamHI fragment
from pRS306-GAL:SWE1myc (33) that carries the COOH terminus of SWE1
tagged as described above was inserted in place of the corresponding untagged
fragment in the YIplac204-SWE1 plasmid to create a full-length myc-tagged
SWE1 expressed from the SWE1 promoter. This plasmid was digested with
EcoRV to target integration to the TRP1 locus. In addition to transformants
containing a single copy of the SWE1myc:TRP1 allele, one transformant con-
tained three copies integrated at TRP1 as determined by Southern blot analysis.
This allele is referred to as SWE1myc:TRP1(3X).
The GAL:HSL1:LEU2 and GAL:HSL7:LEU2 alleles were constructed by sim-
ilar strategies. In each case, the 59 end of the gene was amplified from genomic
DNA by PCR. A BamHI site was incorporated into each primer with the 59 site
just upstream of the start codon. The primers used were 59-TTATTGGATCC
ACACGACATGACTGGTCAC-39 and 59-GTTTATTAGGATCCTCTAATGC
TGCCATGCCG-39 (HSL1) and 59-GGTTCAGGATCCATATGCATAGCAA
CG-39 and 59-CATACGAAGGATCCCTGGTTCTTGGCAAAGC-39 (HSL7).
The PCR products (0.8 kb for HSL1 and 0.7 kb for HSL7) were cut with BamHI
and ligated into the corresponding site of vector YIpG2 (13, 53), which placed
the fragments downstream of the GAL1 promoter. The YIpG2-HSL1 plasmid
was targeted to integrate at the HSL1 locus by digestion with XbaI; this created
a full-length GAL:HSL1:LEU2 allele adjacent to a 39 truncated HSL1. The
YIpG2-HSL7 plasmid was targeted to integrate at the HSL7 locus by digestion
with NruI; this created a full-length GAL:HSL7:LEU2 allele adjacent to a 39
truncated HSL7. To create the GAL:HSL1:LEU2:HSL1:TRP1 allele, a 7.3-kb
BamHI/SacI fragment containing HSL1 and surrounding genomic sequence was
isolated from plasmid pNE30 (11) and ligated into the corresponding sites of the
vector pRS304 (50). The resulting plasmid was digested with StuI to target
integration to the GAL:HSL1:LEU2 locus, creating a strain that contains GAL-
regulated HSL1 adjacent to wild-type HSL1 under its own promoter.
The HSL7-3HA:kan allele was constructed as described by Longtine et al. (27).
To create the HSL1myc:URA3 allele, a 0.65-kb fragment corresponding to the 39
end of HSL1 and including the last coding base of the HSL1 open reading frame
was amplified by PCR with primers (59-CTCTAGAATCTAAAAAAGTAG
GTGGGGG-39 and 59-CGTCGACTGAACGTCCGGCATTTCGAATTAC-
39) that placed an XbaI site upstream of the fragment and a SalI site downstream.
This PCR product was digested with XbaI and SalI and inserted into XbaI/SalI-
digested pRS306-GAL:SWE1myc (33), thus replacing the entire SWE1 open
reading frame and upstream sequences with the COOH-terminal HSL1 frag-
ment. This created an in-frame fusion of the 39 end of HSL1 with the myc tag in
the plasmid. The resulting plasmid was targeted to integrate at the HSL1 locus
by digestion with EcoRI, thus creating the HSL1myc:URA3 allele adjacent to a
59 deleted HSL1.
The mih1DTRP1, bar1DTRP1, and hsl1DTRP1 alleles were constructed by
using the PCR disruption method (5, 28) and plasmid pRS304 (50) as a template.
The PCR products were transformed directly into yeast to delete all or nearly all
of the open reading frames of interest. The PCR primers used were: 59-TGGA
CAAACCAGGATTGAAGTCAGCGAGGGTGAAGAAACCGCGCGTTTC
GGTGATGAC-39 and 59-AATAACGATCTTCTTGCGGGCCTGGGTAAAT
CTTCTCGGTTTTCCTGATGCGGTATTTTCTCCT-39 for MIH1, 59-CCATT
ACTGCTTTAACAAACGATGGCACTGGTCACTTAGAGCGCGTTTCGG
TGATGAC-39 and 59-ACACTGCCCGAATTTGCCATAGTCGAGGATAAT
TCTAATTTAGTTTCCTGATGCGGTATTTTCTCCT-39 for BAR1, and 59-
TCAAATAGGTTGGATATCCATCATACTACTTGCTACTAATGCGCGTT
TCGGTGATGAC-39 and 59-GAATTTATGAACGTCCGGCATTTCGAATT
ACTCTCTCCACTTTCCTGATGCGGTATTTTCTCCT-39 for HSL1. All dis-
ruptions were confirmed by diagnostic PCR (26).
Media, growth conditions, and cell synchrony. Strains were grown in YEPD
(1% yeast extract, 2% Bacto Peptone, 2% dextrose, and 0.01% adenine), YEPS
(YEPD but with 2% sucrose instead of dextrose), or YEPG (YEPD but with 2%
galactose instead of dextrose) medium. For a-factor arrest-release experiments,
exponentially growing cells (2 3 106 to 5 3 106 cells/ml) were incubated with 20
to 25 ng of a-factor (custom synthesized by Research Genetics, Huntsville, Ala.)
per ml for 2 to 3 h, harvested by centrifugation, and resuspended in a fresh
medium to release the a-factor-induced cell cycle block. bar1 strains were used
in all such experiments, and microscopic examination confirmed that .90% of
the arrested cells were unbudded. Cells were arrested in G2/M by incubation with
15 mg of nocodazole (Sigma, St. Louis, Mo.; stored as a 10-mg/ml stock solution
in dimethylsulfoxide at 220°C) per ml for 3 to 4 h (18). Microscopic examination
confirmed that .80% of the treated cells had large buds, indicative of G2/M
arrest.
Fluorescence staining and microscopy. To visualize nuclear DNA, cells were
fixed in 70% ethanol for .1 h, harvested by centrifugation, and resuspended in
0.2 mg of DAPI (496-diamidino-2-phenylindole; Sigma). Cells were viewed on an
Axioskop apparatus (Zeiss, Thornwood, N.Y.) equipped with epifluorescence
and differential interference contrast optics. Images were captured by using a
cooled model charge-coupled device (CCD) camera (Princeton Instruments,
Princeton, N.J.). Microscopic images of whole yeast microcolonies were captured
similarly.
Preparation of lysates, immunoprecipitation, immunoblotting, and phospha-
tase treatment. Yeast cells were washed with ice-cold H2O and harvested by
centrifugation. Cell pellets were stored frozen at 280°C. Lysates were made by
resuspending the pellets in a lysis buffer containing 50 mM Tris-HCl (pH 7.5),





JMY1507.........a SWE1myc:HIS2 hsl1DURA3 hsl7DURA3
JMY1470.........a SWE1myc:HIS2 SWE1myc:TRP1
JMY1477.........a SWE1myc:HIS2 SWE1myc:TRP1 hsl1DURA3
JMY1475.........a SWE1myc:HIS2 SWE1myc:TRP1 hsl7DURA3
JMY1479.........a SWE1myc:HIS2 SWE1myc:TRP1 hsl1DURA3 hsl7DURA3
JMY1569.........a/a swe1DLEU2/SWE1 mih1DLEU2/MIH1 hsl1DURA3/HSL1
JMY1570.........a/a swe1DLEU2/SWE1 mih1DLEU2/MIH1 hsl7DURA3/HSL7
JMY1571.........a/a mih1DTRP1/MIH1 hsl1DURA3/HSL1 GAL:HSL7:LEU2/
HSL7
JMY1572.........a/a mih1DTRP1/MIH1 hsl7DURA3/HSL7 GAL:HSL1:LEU2/
HSL1
DLY657 ..........a cdc24-1 bar1
DLY690 ..........a cdc24-1 swe1DLEU2 bar1
JMY1284.........a GAL:HSL7:LEU2 cdc24-1 bar1
JMY1495.........a GAL:HSL1:LEU2:HSL1:TRP1 cdc24-1 bar1
JMY1472.........a SWE1myc:HIS2 cdc24-1 bar1
JMY1494.........a SWE1myc:HIS2 SWE1myc:TRP1 cdc24-1 bar1
JMY1493.........a SWE1myc:HIS2 SWE1myc:TRP1(3X) cdc24-1 bar1
JMY1300.........a hsl1DURA3 cdc24-1 bar1




M-1537* ..........a GAL:SWE1myc:URA3 HSL7-3HA:kan
JMY1521*.......a GAL:SWE1myc:URA3 HSL7-3HA:kan bar1DTRP1
JMY1539*.......a GAL:SWE1myc:URA3 HSL7-3HA:kan hsl1DTRP1
DLY1 ..............a bar1
RSY342...........a GAL:SWE1myc:URA3 CDC28Y19F:TRP1
RSY361...........a GAL:SWE1myc:URA3 hsl1DURA3 CDC28Y19F:TRP1 bar1
RSY356...........a GAL:SWE1myc:URA3 hsl7DURA3 CDC28Y19F:TRP1 bar1
RSY366...........a GAL:SWE1myc:URA3 GAL:HSL1:LEU2 CDC28Y19F:TRP1
bar1
RSY370...........a GAL:SWE1myc:URA3 GAL:HSL7:LEU2 CDC28Y19F:TRP1
bar1
a *, strains in the YEF473A (6) background (his3 leu2 trp1 ura3 lys2). All other
strains are in the BF264-15DU (43) background (ade1 his2 leu2-3,112 trp1-1a
ura3Dns).
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150 mM NaCl, 5 mM EDTA, 1% NP-40, 1 mM sodium pyrophosphate, 1 mM
phenylmethylsulfonyl fluoride, 1 mM sodium orthovanadate, and 2 mg each of
pepstatin A and leupeptin (Sigma) per ml and vortexing with acid-washed glass
beads. Lysates were clarified by centrifugation for 8 min at 14,000 rpm in an
Eppendorf Microfuge, and the protein concentration was determined by using
the Bio-Rad (Hercules, Calif.) protein assay.
For electrophoresis and immunoblotting, 20 mg of total protein per gel lane
were mixed with hot (95°C) 23 sample loading buffer (final concentrations, 62.5
mM Tris-HCl [pH 6.8], 1% sodium dodecyl sulfate [SDS], 25% glycerol, 355 mM
b-mercaptoethanol, 0.01% bromophenol blue) and incubated at 95°C for 5 min
prior to electrophoresis on SDS–6 or 8% polyacrylamide gels. Proteins were then
transferred electrophoretically to nitrocellulose membranes (Schleicher and
Schuell, Keene, N.H.) and stained with anti-myc (9E10; Santa Cruz Biotechnol-
ogy, Santa Cruz, Calif.) or anti-HA (12CA5; Boehringer Mannheim, Indianap-
olis, Ind.) antibody. Before staining, membranes were blocked with 5% nonfat
dry milk in phosphate-buffered saline (PBS) containing 0.1% Tween 20 (PBS-
Tween). Primary antibodies were used at a 1:1,000 dilution in PBS-Tween con-
taining 1% nonfat dry milk. The secondary antibody (horseradish peroxidase-
conjugated goat anti-mouse immunoglobulin G; Jackson Immunoresearch
Laboratories, West Grove, Pa.) was used at a 1:2,500 dilution in the same
solution. Incubations were carried out for 1 h each and separated by three washes
with PBS-Tween. Blots were developed with Renaissance Western Blot Chemi-
luminescence Reagent Plus (NEN Life Sciences Products, Boston, Mass.).
For immunoprecipitation, 200 mg of lysate was incubated for 1 h with 1 ml of
antibody and then for a further 1 h with 30 ml of a 50% slurry of protein
A-Sepharose (Sigma) at 4°C with gentle rocking. Beads were washed three times
with lysis buffer (see above) without protease inhibitors and then heated in 13
sample loading buffer, and proteins were separated and immunoblotted as de-
scribed above.
For phosphatase treatment of Hsl7p-HA, anti-HA immunoprecipitate from
400 mg of lysate was washed twice with lysis buffer (see above) and twice with a
solution containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM sodium
pyrophosphate, 1% Triton X-100, 1% sodium deoxycholate, and 0.1% SDS and
then divided into three equal aliquots. These aliquots were resuspended in 40
mM PIPES (piperazine-N,N9-bis[2-ethanesulfonic acid]) (pH 6.0) containing 1
mM dithiothreitol, 7.5 mM phenylmethylsufonyl fluoride, 37.5 mg of aprotinin
(Sigma) per ml, and 25 mg each of benzamidine (Sigma), leupeptin, and pepsta-
tin A per ml. Type II potato acid phosphatase (0.14 U) (Sigma) was added to two
of the samples, and all samples were incubated at 30°C for 30 min. Sodium
orthovanadate (10 mM) was added to inhibit phosphatase activity in one of the
samples.
Pulse-chase analysis of Swe1p-myc stability. GAL:SWE1myc:URA3 cells were
grown in YEPS at 30°C and induced to express Swe1p-myc by the addition of 2%
galactose for 10 min or 3 h. Cells were then harvested by centrifugation, resus-
pended at a density of 108 cells/ml in a labeling medium (6.7 g of yeast nitrogen
base without methionine and cysteine [Bio 101, Vista, Calif.] per liter, 2%
sucrose, and 2% galactose, plus 0.25 mCi of Trans35S-Label [ICN Pharmaceu-
ticals, Costa Mesa, Calif.] per ml [0.183 mM]) and incubated for a further 10 min
to label newly synthesized proteins with [35S]methionine and cysteine. Labeled
cells were collected by filtration, washed with a prewarmed medium, and resus-
pended at a density of 3 3 107 cells/ml in fresh YEPD or YEPG supplemented
with 3 mM methionine and 0.5% Casamino Acids to prevent further labeling.
Incubation was continued, and aliquots of cells were diluted into ice-cold 10 mM
NaN3, harvested by centrifugation, washed with ice-cold 10 mM NaN3, and
frozen at 280°C. For some experiments, the protocol was modified as follows:
a-factor (50-ng/ml final concentration) or nocodazole (15-mg/ml final concentra-
tion) was added 1 h prior to the addition of galactose, and subsequent incuba-
tions were performed in media containing the same concentration of a-factor or
nocodazole.
For analysis, cell pellets were lysed as described above, and Swe1p-myc was
immunoprecipitated by using anti-myc antibody (see above) from samples con-
taining 3 mCi of radioactive label. Immunoprecipitates were washed three times
with a lysis buffer, heated for 5 min in 13 sample loading buffer, and separated
in SDS–8% polyacrylamide gels. Dried gels were exposed to a Molecular Dy-
namics (Sunnyvale, Calif.) storage phosphor screen for 24 to 48 h, scanned on a
Molecular Dynamics model 445 SI PhosphorImager, and analyzed with Image-
Quant, version 1.2 software.
RESULTS
Negative regulation of Swe1p in unperturbed cells by a path-
way involving both Hsl1p and Hsl7p. Swe1p-mediated inhibi-
tion of Cdc28p leads to a G2 delay during which bud growth
continues primarily at the bud tip, resulting in a distinctive
elongated-bud morphology (7, 23). The finding that hsl1 and
hsl7 mutants exhibited a SWE1-dependent elongated-bud phe-
notype originally suggested that Hsl1p and Hsl7p might be
negative regulators of Swe1p (29). However, the mutant phe-
notypes are quite variable depending on the strain background
and growth conditions (54; see below), raising the question of
how generally this conclusion might apply. For example, in our
strain background, the deletion of HSL1 or HSL7 did not
cause a pronounced phenotype in cells growing exponentially
on our standard medium (Fig. 1A, panels 1 to 3). However,
when the populations approached the stationary phase, a frac-
tion of the hsl1D and hsl7D cells displayed elongated buds; this
effect was not seen if SWE1 was also deleted (data not shown).
In addition, doubling the copy number of SWE1, a manipula-
tion that has little effect on otherwise wild-type cells (Fig. 1A,
panel 5), caused a pronounced elongated-bud phenotype in
hsl1D or hsl7D cells even during exponential growth (Fig. 1A,
panels 6 and 7).
The phosphatase Mih1p antagonizes Swe1p activity by re-
versing the Swe1p-catalyzed phosphorylation of Cdc28p (45).
In the course of other studies, we observed that the steady-
state levels of Mih1p declined as populations approached the
stationary phase (32), perhaps explaining why hsl1D or hsl7D
strains would show a Swe1p-dependent G2 delay only at high
cell densities (see above). To investigate further the interplay
among Swe1p, Mih1p, and Hsl1p-Hsl7p, we constructed dou-
ble-mutant and triple-mutant strains. Although the deletion of
MIH1 (Fig. 1B, panel 5), like the deletion of HSL1 or HSL7
(Fig. 1B, panels 2 and 6), has little effect in otherwise wild-type
cells, both hsl1D mih1D and hsl7D mih1D double mutants were
inviable and produced extremely elongated buds, suggestive of
G2 arrest (Fig. 1B, panels 3 and 7). The deletion of SWE1
restored normal growth to these strains (Fig. 1B, panels 4 and
8), confirming that the G2 arrest was a result of Swe1p activity.
Taken together, these data suggest that Hsl1p and Hsl7p
indeed function generally as negative regulators of Swe1p. This
negative regulation appears to play a minor role in unper-
turbed cells unless the activity of Swe1p is artificially increased
or the activity of Mih1p is decreased to the point that it cannot
effectively antagonize the action of the unregulated Swe1p.
To ask if Hsl1p and Hsl7p function in the same or separate
pathways for regulation of Swe1p, we constructed hsl1D hsl7D
double-mutant strains. Like the hsl1D and hsl7D single mu-
tants, a double mutant that was otherwise wild type showed no
conspicuous abnormalities during exponential growth (Fig. 1A,
panel 4). Upon approach to the stationary phase (data not
shown) or when the SWE1 copy number was doubled (Fig. 1A,
panel 8), the double mutant displayed elongated buds, but this
phenotype did not appear more severe than those of the single
mutants. This panel of strains provides a very sensitive readout
of Swe1p activity, because doubling the SWE1 dose has a large
effect. Thus, the absence of an additive or synergistic effect in
the double mutant implies that it has no more active Swe1p
than the single mutants, suggesting that Hsl1p and Hsl7p act in
the same pathway to inhibit Swe1p.
We attempted to order the actions of Hsl1p and Hsl7p in
this pathway by testing whether the overexpression of either
gene could compensate for the loss of the other. However, no
such rescue was observed (Fig. 1C), suggesting that neither
Hsl1p nor Hsl7p can effectively down-regulate Swe1p on its
own and hence that these proteins play interdependent roles in
the same step of Swe1p control.
Function of Hsl1p and Hsl7p during the morphogenesis
checkpoint response. If Hsl1p and Hsl7p really act directly as
negative regulators of Swe1p, then excess Hsl1p or Hsl7p
might cause an inappropriate inhibition of Swe1p that could
override the G2 delay imposed by the morphogenesis check-
point. To test this possibility, we generated strains that ex-
pressed HSL1 or HSL7 under the control of the regulatable
GAL1 promoter and also harbored a temperature-sensitive
cdc24 mutation. At a restrictive temperature, the cdc24 mutant
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FIG. 1. Negative regulation of Swe1p in unperturbed cells by a pathway involving both Hsl1p and Hsl7p. (A) G2 delay (resulting in bud elongation) when SWE1
copy number is doubled in the absence of Hsl1p, Hsl7p, or both. Wild-type (WT) (JMY1469), hsl1D (JMY1503), hsl7D (JMY1505), and hsl1D hsl7D (JMY1507) strains
and related strains containing an extra copy of SWE1 (JMY1470, JMY1477, JMY1475, and JMY1479) were observed by using differential interference contrast optics
during exponential growth (5 3 106 cells/ml) in YEPD medium. (B and C) Genetic interactions among SWE1, HSL1, HSL7, and MIH1. (B) Diploid strains JMY1569
(upper row) and JMY1570 (lower row) were sporulated to generate haploid segregants with the indicated genotypes (confirmed by replica plating and analysis of marker
genes). Following tetrad dissection, spores were allowed to grow on YEPD medium for 2 days before the resulting microcolonies were photographed (C). Diploid strains
JMY1571 (panels 1 and 2) and JMY1572 (panels 3 and 4) were sporulated, and spores of the indicated genotypes were grown on YEPG medium to induce over-
expression of the GAL-regulated genes.
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is unable to polarize actin and consequently exhibits a pro-
longed Swe1p-dependent G2 delay (1, 22, 52) (Fig. 2A). How-
ever, when Hsl7p was overexpressed by growing the GAL:
HSL7 strain on galactose, the G2 delay was virtually eliminat-
ed, and the cells traversed mitosis with kinetics similar to those
of cells that lacked Swe1p altogether (Fig. 2A). The corre-
sponding experiment for Hsl1p was more complicated because
the constitutive overexpression of Hsl1p caused a Swe1p-inde-
pendent growth defect associated with severe morphological
aberrations (data not shown). However, when this problem was
circumvented by growing the GAL:HSL1 cells on galactose for
only a short time, it was clear that the overexpression of Hsl1p
could also override the checkpoint-induced G2 delay of cdc24
cells (Fig. 2B). It is not clear whether the less complete over-
ride of the checkpoint in this experiment reflects intrinsic dif-
ferences in the abilities of Hsl1p and Hsl7p to inhibit Swe1p
or simply a lesser degree of overexpression in the Hsl1p ex-
periment. Nevertheless, these data suggest strongly that both
Hsl1p and Hsl7p are bona fide negative regulators of Swe1p.
To investigate whether Hsl1p and Hsl7p normally play a role
in the morphogenesis checkpoint response, we examined this
response in cells with HSL1 or HSL7 deleted. Under the con-
ditions used, the duration of the G2 delay is very sensitive to
SWE1 gene dosage (49) (Fig. 3A). Nonetheless, the deletion of
HSL1 or HSL7 did not produce a detectable lengthening of the
G2 delay in the cdc24 mutant (Fig. 3B). The simplest interpre-
tation of this result is that Hsl1p and Hsl7p are already turned
off when the checkpoint response is induced, so that deleting
the genes produces no additional increase in Swe1p activity
(or, thus, in G2 delay) under these conditions.
Periodic accumulation of Hsl1p during the cell cycle. To
examine the behavior of Hsl1p and Hsl7p during the cell cycle,
we generated strains expressing epitope-tagged versions of
these proteins. The Hsl1p-myc and Hsl7p-HA proteins (ex-
pressed under the control of their own promoters at their
normal genomic loci) were fully functional by the criteria that
HSL1myc:URA3 mih1DLEU2 and HSL7-3HA:kan mih1DLEU2
strains were viable and had normal cell morphology (data not
shown). In synchronized cells, Hsl1p-myc was absent in G1,
accumulated during S phase to a peak in G2/M, and disap-
peared coincident with nuclear division (Fig. 4A). This pattern
of protein accumulation is consistent with the previously de-
scribed pattern of HSL1 mRNA accumulation, which is peri-
odic with a peak in late G1 (54).
Periodic Hsl1p-dependent phosphorylation of Hsl7p. In
contrast to Hsl1p, Hsl7p was present at approximately constant
levels throughout the cell cycle (Fig. 4B). However, a fraction
of the Hsl7p protein was modified in a cell cycle-dependent
manner, as indicated by the periodic appearance of a more
slowly migrating species (Fig. 4B). This species was also ap-
FIG. 2. Override of the morphogenesis checkpoint by overexpression of
HSL1 or HSL7. (A) Strains DLY657 (cdc24-1 SWE1) (E), DLY690 (cdc24-1
swe1D) (F), and JMY1284 (cdc24-1 SWE1 GAL:HSL7:LEU2) (h) were grown
overnight at 24°C (permissive temperature) in YEPG to induce the GAL pro-
moter, synchronized in G1 phase with a-factor, and released into fresh YEPG at
37°C (restrictive temperature), where actin polarization and bud formation did
not occur. At 30-min intervals, cells were fixed and stained to monitor the
kinetics of nuclear division; 200 cells were scored in each sample. (B) Strains
DLY657 (E), DLY690 (F), and JMY1495 (cdc24-1 SWE1 GAL:HSL1:LEU2)
(h) were grown at 24°C in YEPS (noninducing nonrepressing medium for the
GAL promoter) and arrested in G1 phase with a-factor. Galactose was then
added to induce the GAL promoter, and 1 h later the cells were released into
fresh YEPG at 37°C and monitored as described above.
FIG. 3. Equivalent checkpoint delays in Hsl1 and Hsl2 cells. (A) Strains
JMY1472 (cdc24-1 SWE1) (E), DLY690 (cdc24-1 swe1D) (F), JMY1494 (cdc24-
1 2xSWE1) (h), and JMY1493 (cdc24-1 4xSWE1) (‚) were grown at 24°C (per-
missive temperature), synchronized in G1 phase with a-factor, and released at
37°C (restrictive temperature), where actin polarization and bud formation did
not occur. At 30-min intervals, cells were fixed and stained to monitor the ki-
netics of nuclear division; 200 cells were scored in each sample. (B) Strains
DLY657 (cdc24-1 SWE1) (E), DLY690 (F), JMY1300 (cdc24-1 SWE1 hsl1D)
(h), and JMY1301 (cdc24-1 SWE1 hsl7D) (‚) were synchronized and analyzed
as described for panel A.
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parent in cells that had been arrested in G2 by overexpression
of Swe1p (Fig. 4C, lane 2), suggesting that Clb1p-4p–Cdc28p
activity was not required for Hsl7p modification. Because the
appearance of the modified Hsl7p protein was correlated with
the peak in Hsl1p abundance during the cell cycle, we tested
whether the modification was Hsl1p dependent. Indeed, the
modified Hsl7p protein was not detectable in an hsl1D strain
(Fig. 4C, lane 4). The modified Hsl7p protein disappeared
following phosphatase treatment (Fig. 4D), indicating that the
modification was phosphorylation. Thus, Hsl1p promotes the
periodic phosphorylation of Hsl7p. It is not yet clear whether
this effect is direct or indirect.
Hsl1p-independent association of Hsl7p with Swe1p. To de-
termine if the negative regulation of Swe1p by Hsl7p reflects a
FIG. 4. Characterization of Hsl1p and Hsl7p. (A) Periodic accumulation of Hsl1p during the cell cycle. Wild-type cells expressing Hsl1p-myc (strain JMY1500) were
grown in YEPD, synchronized in G1 phase with a-factor, and released into a fresh medium. Cells were harvested at the indicated times, and separate aliquots were
lysed to detect Hsl1p or fixed to monitor bud formation and nuclear division. Hsl1p-myc was immunoprecipitated from lysates containing 200 mg of total protein,
separated by SDS-polyacrylamide gel electrophoresis (PAGE), and immunoblotted with anti-myc antibody. (B to D) Hsl1p-dependent phosphorylation of Hsl7p during
the cell cycle. (B) Wild-type cells expressing Hsl7p-HA (strain JMY1521) were synchronized as described above. Lysates containing 20 mg of total protein were
separated by SDS-PAGE, and Hsl7p-HA was detected by immunoblotting with anti-HA antibody. (C) Lysates were prepared from an Hsl7p-HA-expressing strain
(JMY1521) that had been arrested in G1 phase with a-factor (lane 3) and from cells of strains expressing or lacking Hsl7p-HA, Swe1p-myc (GAL regulated), and Hsl1p
as indicated (lane 1, M-1505; lane 2, M-1537; and lane 4, JMY1539) that had been arrested in G2 phase by growth for 3 h after galactose was added to induce
overexpression of Swe1p-myc. Proteins were separated by SDS-PAGE and Hsl7p-HA was detected by immunoblotting with anti-HA antibody. (D) Anti-HA
immunoprecipitates were prepared from lysate of a strain (M-1537) expressing Hsl7p-HA and divided into three equal aliquots that were subjected to a mock
phosphatase treatment (lane 1), treatment with potato acid phosphatase (lane 2), or treatment with phosphatase together with the phosphatase inhibitor sodium
orthovanadate (lane 3). Proteins were separated by SDS-PAGE, and Hsl7p-HA was detected by immunoblotting with anti-HA antibody. (E) Coimmunoprecipitation
of Hsl7p-HA with Swe1p-myc. Lysates were prepared from strains expressing Hsl7p-HA, Swe1p-myc (GAL regulated), and/or Hsl1p, as indicated (lane 1, M-1505; lane
2, M-1295; lane 3, M-1537; and lane 4, JMY1539), that had been arrested in G2 phase as described for panel C. Lysate was also prepared from a strain expressing both
tagged proteins that had been arrested in G1 phase with a-factor (JMY1521 [lane 5]). Anti-myc immunoprecipitates were prepared from samples containing 200 mg
of total protein, separated by SDS-PAGE, and immunoblotted with anti-myc (upper blot) or anti-HA (lower blot) antibody.
6934 MCMILLAN ET AL. MOL. CELL. BIOL.
physical interaction, we tested for coimmunoprecipitation of
these proteins. Indeed, when immunoprecipitates were pre-
pared with anti-myc antibodies from cells expressing both
Swe1p-myc and Hsl7p-HA, the latter protein was readily de-
tected by immunoblotting (Fig. 4E, lane 3). In control exper-
iments with cells expressing just one of the tagged proteins, no
Hsl7p-HA was detected (Fig. 4E, lanes 1 and 2). Both phos-
phorylated and unphosphorylated forms of Hsl7p were coim-
munoprecipitated with Swe1p (Fig. 4E, lane 3), and the asso-
ciation did not depend on Hsl1p (Fig. 4E, lane 4) and was
detectable in cells arrested in G1 by a-factor (Fig. 4E, lane 5).
These data are consistent with the hypothesis that Hsl7p is a
direct regulator of Swe1p.
Dependence of Swe1p degradation on Hsl1p and Hsl7p dur-
ing the unperturbed cell cycle. Swe1p is normally stabilized in
response to activation of the morphogenesis checkpoint (see
the introduction). If the checkpoint acts (at least in part) by
down-regulation of Hsl1p and/or Hsl7p, then the deletion of
HSL1 or HSL7 should also result in Swe1p stabilization. In-
deed, pulse-chase experiments (Fig. 5) showed that Swe1p was
dramatically stabilized in both hsl1D and hsl7D strains, relative
to the wild type, suggesting that Hsl1p and Hsl7p are required
to target Swe1p for degradation.
Cell cycle-specific acceleration of Swe1p degradation by
overexpression of Hsl1p. If Hsl1p or Hsl7p is rate limiting for
Swe1p degradation, then the overexpression of one or both of
these proteins might accelerate Swe1p degradation. To test
this possibility, we performed pulse chase experiments in
strains that simultaneously overexpressed Swe1p and Hsl1p or
Swe1p and Hsl7p. It was observed previously that the overex-
pression of Swe1p in such experiments slows its degradation,
presumably by saturating the capacity of a limiting component
involved in Swe1p degradation (48) (also compare WT in Fig.
6 with WT in Fig. 5, in which Swe1p was not overexpressed).
Strikingly, the overexpression of Hsl1p (but not of Hsl7p)
accelerated Swe1p degradation (Fig. 6), suggesting that Hsl1p
levels are rate limiting for Swe1p degradation, at least under
conditions of overexpression.
Swe1p is normally stable during G1 and unstable during
G2/M (48). Given the data described above, it seemed possible
that the stability of Swe1p in G1 cells might be due simply to
the absence of Hsl1p. The acceleration of Swe1p degradation
upon overproduction of Hsl1p (Fig. 6) might reflect either
more efficient degradation during G2/M, inappropriate degra-
dation during G1, or both. To distinguish among these possi-
bilities, we repeated the experiment whose results are shown in
Fig. 6 with cells synchronized in G1 with a-factor or in G2/M
with nocodazole. As shown in Fig. 7A, Swe1p was stable in G1
cells even when Hsl1p was overexpressed. In contrast, excess
Hsl1p promoted more rapid Swe1p degradation in the G2/M-
arrested cells (Fig. 7B). Thus, Hsl1p appears to be rate limiting
for degradation of overproduced Swe1p, but only at later
stages of the cell cycle, suggesting the existence of a cell cycle-
regulated step in Swe1p degradation in addition to the periodic
accumulation of Hsl1p.
DISCUSSION
Down-regulation of Swe1p by Hsl1p and Hsl7p. It was ob-
served previously that hsl1 and hsl7 mutants display a Swe1p-
dependent G2 delay, suggesting that Hsl1p and Hsl7p act as
negative regulators of Swe1p (29). However, many mutants
defective for aspects of cell morphogenesis also display Swe1p-
dependent G2 delays (22, 33), so that it was not clear whether
Hsl1p and Hsl7p were involved primarily in morphogenesis or
acted more directly on Swe1p. Our finding that the overexpres-
sion of Hsl1p or Hsl7p can override a morphogenesis check-
point-induced G2 delay provides a strong argument that these
proteins function directly in down-regulating Swe1p. This down-
regulation appears to depend, at least in part, on targeting
Swe1p for degradation. The stability of Swe1p normally varies
FIG. 5. Stabilization of Swe1p in hsl1D and hsl7D strains. (A) CDC28Y19F
GAL:SWE1myc strains RSY342 (wild type [WT]) (HSL1 HSL7) (top), RSY361
(hsl1D HSL7) (middle), and RSY356 (HSL1 hsl7D) (bottom) were grown in
YEPS and induced to express Swe1p-myc by 10 min of growth in the presence of
galactose. The cells were harvested, pulse labeled with [35S]methionine and
cysteine for 10 min, harvested again, and resuspended in fresh YEPD (to repress
the GAL promoter) containing nonradioactive methionine and cysteine. The
amounts of 35S-labeled Swe1p-myc were determined at intervals by immunopre-
cipitation and SDS-PAGE. Cells of a strain (DLY1) not expressing Swe1p-myc
were pulse labeled and processed as described above, providing a control shown
in the left-hand lane of each gel. The asterisk indicates a labeled band that is
present in cells lacking Swe1p-myc (left lanes) and binds to the protein A beads
used for immunoprecipitation. (B) The radioactive signals from the gels shown
in panel A were quantitated with a phosphorimager. These experiments were
performed with CDC28Y19F strains to avoid potential complications arising from
the dependence of Swe1p degradation on Cdc28p activity (48); i.e., if the Swe1p
produced during the pulse substantially inhibited Cdc28p, an artifactual stabili-
zation of Swe1p might be observed during the chase period. However,
Cdc28pY19F, which lacks the Swe1p phosphorylation site, is largely resistant to
inhibition by Swe1p. We confirmed that cell proliferation indeed continued
through the pulse-chase protocol in all strains (data not shown).
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during the cell cycle: it is moderately stable during G1 and
becomes quite unstable in G2/M (48). Our data indicate that
both Hsl1p and Hsl7p are required for the rapid degradation
of Swe1p and that Hsl1p is rate limiting for Swe1p degradation,
at least under conditions of Swe1p overexpression. In addition,
the genetic data indicate that Hsl1p and Hsl7p act in a single
pathway to down-regulate Swe1p and that neither one can
effectively down-regulate Swe1p in the absence of the other.
It has been shown previously that Swe1p degradation in-
volves its ubiquitination by a complex, called SCFMet30, that
contains the F box protein Met30p and the ubiquitin-conjugat-
ing enzyme Cdc34p (19). Detailed analyses of the ubiquitina-
tion of the Cdc28p inhibitor Sic1p by a similar complex, SCF-
Cdc4, have revealed that phosphorylation of Sic1p is a necessary
prelude to its ubiquitination and subsequent degradation (3,
12, 31, 51). Swe1p, like Sic1p, becomes hyperphosphorylated
prior to its degradation (48). Thus, it is plausible that a part of
this hyperphosphorylation is due to Hsl1p (in conjunction with
Hsl7p) and that this phosphorylation targets Swe1p for recog-
nition and ubiquitination by SCFMet30. Swe1p degradation also
requires Clb-Cdc28p activity (48). Our data indicate that Hsl1p
overexpression accelerates Swe1p degradation during G2/M
but is unable to do so during G1. Taken together, the data
suggest that Clb-Cdc28p activity is required either to activate
Hsl1p-Hsl7p or to collaborate with Hsl1p-Hsl7p in targeting
Swe1p for degradation (Fig. 8A).
The conclusion that Hsl1p is a negative regulator of Swe1p
was anticipated because the Hsl1p kinase domain (although
not the large noncatalytic domain) is closely related to that of
S. pombe Nim1, which is a negative regulator of Wee1. How-
ever, the finding that Hsl1p targets Swe1p for degradation was
surprising, because Nim1 has been shown to phosphorylate
Wee1 directly, inhibiting its kinase activity (9, 40, 55). We do
FIG. 6. Acceleration of Swe1p degradation by overexpression of Hsl1p. (A)
CDC28Y19F GAL:SWE1myc strains RSY342 (WT), RSY366 (GAL:HSL1), and
RSY370 (GAL:HSL7) were grown in YEPS and induced to overexpress the
GAL-regulated genes by addition of galactose for 3 h. The cells were harvested,
pulse labeled with [35S]methionine and cysteine for 10 min, harvested again, and
resuspended in fresh YEPG containing nonradioactive methionine and cysteine.
The amount of 35S-labeled Swe1p-myc was determined by immunoprecipitation
and SDS-PAGE. The asterisk indicates a labeled band that is present in cells
lacking Swe1p-myc (left lanes) and binds to the protein A beads used for im-
munoprecipitation. (B) The radioactive signals from the gels shown in panel A
were quantitated with a phosphorimager.
FIG. 7. Cell cycle specificity of the acceleration of Swe1p degradation by
overexpression of Hsl1p. CDC28Y19F GAL:SWE1myc strains RSY342 (WT) and
RSY366 (GAL:HSL1) were grown in YEPS and induced to overexpress the
GAL-regulated genes by addition of galactose. Just after galactose addition, the
culture was split, and a-factor (50 ng/ml) was added to one set (A) while
nocodazole (15 mg/ml) was added to the other (B). After incubation for 4 h, the
cells were harvested, pulse labeled with [35S]methionine and cysteine for 10 min,
harvested again, and resuspended in fresh YEPG containing nonradioactive
methionine and cysteine. The labeling and chase media also contained a-factor
or nocodazole to maintain the cell cycle arrest throughout. The amount of
35S-labeled Swe1p-myc remaining was determined by immunoprecipitation and
SDS-PAGE.
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not yet known whether Hsl1p can phosphorylate Swe1p direct-
ly and/or inhibit Swe1p kinase activity. Similarly, it is not known
whether Nim1 influences Wee1 degradation in S. pombe, and it
is possible that the phosphorylation of Swe1p by Hsl1p and of
Wee1 by Nim1 functions both to inhibit their kinase activity
and to target them for degradation. However, it is also possible
that Hsl1p phosphorylates other substrates that are important
for Swe1p degradation. One candidate is Hsl7p, which is in
constant abundance through the cell cycle but is phosphory-
lated in an Hsl1p- and cell cycle-dependent manner; the cell
cycle dependence may reflect the periodic accumulation of
Hsl1p.
In addition to Hsl1p, there are two other Nim1-related ki-
nases in S. cerevisiae, Gin4p and Ycl024Wp/Kcc4p (2, 4, 17, 25,
29, 39, 54). All of these kinases have diverged from Nim1 to
similar extents (4, 17, 25), suggesting that they might play a
redundant role in the down-regulation of Swe1p. However,
Hsl7p phosphorylation did not occur, and Swe1p was com-
pletely stabilized in hsl1D mutants even though Gin4p and
Kcc4p were present. These data suggest that Hsl1p (together
with Hsl7p) plays a unique role in Swe1p regulation that is not
shared with Gin4p or Kcc4p. The hypothesis that the Nim1-
related kinases play distinct roles in S. cerevisiae is supported
by the finding that Gin4p, but not Hsl1p or Kcc4p, is important
for proper septin organization (25, 27).
Hsl7p is also important for targeting Swe1p for degradation.
Hsl7p is a member of a protein family that is highly conserved
across species but has no known biochemical activity or infor-
mative sequence motifs. Coimmunoprecipitation experiments
indicate that Hsl7p is physically associated with Swe1p and that
this association does not require the phosphorylation of Hsl7p
or the presence of Hsl1p. Furthermore, the Hsl7p-Swe1p as-
sociation also occurs in G1-arrested cells, in which Swe1p is not
hyperphosphorylated (48). These data suggest that the Swe1p-
Hsl7p interaction might be a very early step in the targeting of
Swe1p for degradation, preceding the accumulation of Hsl1p,
the phosphorylation of Hsl7p, and the hyperphosphorylation
of Swe1p (Fig. 8A).
In contrast to the apparent role of Hsl7p as a negative
regulator of Swe1p, a recent study with S. pombe failed to
identify a role for the Hsl7p homolog, Skb1, in regulating
Wee1 (15). Instead, genetic interactions between skb1, wee1,
and cdc25 mutations suggested that Skb1, like Wee1, acts to
delay entry into mitosis (15). It is not clear how to reconcile the
seemingly opposite roles suggested for Hsl7p and Skb1, but it
seems possible that the genetic interactions observed in S.
pombe reflect an effect of skb1 mutations in perturbing mor-
phogenesis (or other processes) rather than a direct effect of
Skb1 in cell cycle control.
Hsl1p, Hsl7p, and the morphogenesis checkpoint. Although
Hsl1p and Hsl7p down-regulate Swe1p in unperturbed cells,
hsl1D and hsl7D mutations appear to have no effect on Swe1p
function in cdc24 mutant cells undergoing a checkpoint re-
sponse. This suggests either that Hsl1p and/or Hsl7p is itself
down-regulated under checkpoint-inducing conditions (the
model we prefer [Fig. 8B]) or that Swe1p is somehow pro-
tected from the action of Hsl1p and Hsl7p under these condi-
tions.
We and others have shown that Hsl1p and Hsl7p, together
with a fraction of cellular Swe1p, are localized to the mother-
bud neck in a septin-dependent manner (4, 27, 36, 47). In
addition, Barral et al. (4) made the intriguing observation that
Hsl1p kinase activity (assayed by autophosphorylation in vitro)
declined in septin mutants, suggesting that Hsl1p activity is
dependent upon its proper localization. Because cdc24 mu-
tants fail to assemble a septin ring (20, 41), this suggests that
Hsl1p would be inactive in these mutants, thus providing a
mechanism for the proposed down-regulation of Hsl1p-Hsl7p
by the morphogenesis checkpoint.
However, the model that the morphogenesis checkpoint-
induced G2 delay is due simply to Hsl1p delocalization in
response to septin defects (4) is inconsistent with much of the
available data. First, the checkpoint override observed in a
cdc24 mutant upon overexpression of Hsl1p or Hsl7p indicates
that these proteins are able to function in the absence of
assembled septins or neck structures, at least when present in
excess. Second, Swe1p-dependent G2 delays are triggered by
several conditions (e.g., osmotic shock or treatment with la-
trunculin A in wild-type cells; tpm1D mutations) that affect the
actin cytoskeleton but do not appear to affect septin organiza-
tion or the mother-bud neck (33). Indeed, treatment with la-
trunculin A did not displace Hsl1p or Hsl7p from the neck
(27). These conditions all cause Swe1p stabilization (48), sug-
gesting that Hsl1p and Hsl7p are no longer effective in target-
FIG. 8. Model for control of the S. cerevisiae cell cycle by the morphogenesis
checkpoint. During the unperturbed cell cycle (A), Hsl1p and Hsl7p promote
Swe1p hyperphosphorylation (P) leading to recognition by SCFMet30, which
catalyzes polyubiquitination (Ub), resulting in the subsequent degradation of
Swe1p. Clb-Cdc28p complexes also contribute to Swe1p degradation, acting
either through Hsl1p-Hsl7p or separately on Swe1p. Although Hsl7p can bind to
Swe1p in the absence of Hsl1p, the fate of the complex may be regulated by
Hsl1p-mediated phosphorylation of Hsl7p. The net effect of these interactions is
to promote Swe1p degradation in G2/M phase, which promotes the activation of
Clb-Cdc28p complexes and hence the unimpeded progression of cells through
mitosis. (Note, however, that the activity of Mih1p appears normally to be high
enough to keep Clb-Cdc28p largely in the active state even if Swe1p degradation
does not occur on schedule.) Following perturbation of the actin cytoskeleton
(B), the morphogenesis checkpoint inhibits Hsl1p-Hsl7p, thus preventing Swe1p
degradation. However, Swe1p stabilization alone is insufficient to promote G2
arrest, and other checkpoint-responsive pathways must also act to regulate
Swe1p and/or Mih1p, so that the balance of their activities is tilted in favor of the
phosphorylation and inhibition of Cdc28p, leading to G2 arrest.
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ing Swe1p for degradation. It seems possible that the ability of
Hsl1p and Hsl7p to down-regulate Swe1p can itself be down-
regulated by more than one mechanism, but further research
will be needed to test this hypothesis and to elucidate the
pathway(s) involved.
Whatever the detailed mechanism(s) responsible for the
checkpoint-induced stabilization of Swe1p, the data presented
here also demonstrate that relieving the down-regulation of
Swe1p by Hsl1p and Hsl7p is not sufficient to explain the
checkpoint-induced G2 delay. In our strain background, the
deletion of HSL1 or HSL7 did not induce a detectable G2
delay in otherwise wild-type cells during exponential growth,
indicating that the G2 delay caused by the morphogenesis
checkpoint must involve additional pathways. Such pathways
could include an increase in Swe1p specific activity, a change in
Swe1p localization, or an inhibition of Mih1p, the phosphatase
that counteracts Swe1p-mediated phosphorylation of Cdc28p
(Fig. 8B). The last mechanism certainly has the potential to
combine very effectively with Hsl1p-Hsl7p down-regulation, as
hsl1D mih1D and hsl7D mih1D cells undergo a lethal Swe1p-
dependent G2 arrest.
Conclusions. We report here that Hsl1p and Hsl7p play a
direct role in targeting Swe1p for degradation, and we suggest
that down-regulation of the Hsl1p-Hsl7p pathway plays a role
in the morphogenesis checkpoint response. Homologs of
Hsl1p and Hsl7p have been identified in many species (8, 15,
21, 29). In S. cerevisiae, the control of Swe1p degradation is
linked to the morphogenesis checkpoint. However, Wee1 deg-
radation in Xenopus is regulated by the DNA replication
checkpoint (34). It may be that a conserved degradation con-
trol pathway has been linked to different checkpoint sensors in
different cells.
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